CNSP vs CRL · $6.6M cap vs rev $2.00B
CNS Pharmaceuticals Inc (CNSP) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
CNSP does not have a complete income-statement cache yet.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CNSP currently screens at market cap $6.6M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CNSP and CRL stock pages for the full models.
Not investment advice.